# Recommendation Memo

## Executive Summary

This analysis evaluated the effectiveness of a new onboarding and activation campaign designed to improve user conversion and early engagement for a subscription-based digital product.

Users were randomly assigned to either a Control group (existing onboarding experience) or a Treatment group (new onboarding experience). The objective was to determine whether the Treatment experience should be rolled out to all users.

Results show that the Treatment experience significantly improved the primary business metric, Paid Conversion Rate, while also increasing user engagement and reducing the average time required to convert. Statistical testing confirmed that the improvement was significant and unlikely to be caused by random variation.

Although increases in support tickets and refund requests were observed, the overall business impact remains positive. Based on the results, a phased rollout of the Treatment experience is recommended.

---

# North Star Metric

## Paid Conversion Rate

### Definition

Paid Conversion Rate = Number of Users Converted to Paid ÷ Total Users

### Why This Metric Was Selected

Paid Conversion Rate was selected as the North Star Metric because:

- It directly measures the effectiveness of the onboarding experience.
- It is strongly tied to subscription revenue growth.
- It aligns with the company's primary business objective of increasing paying customers.
- It provides a clear success criterion for the experiment.

---

# KPI Tree Explanation

The KPI framework for this experiment was structured around Paid Conversion Rate.

## North Star Metric

**Paid Conversion Rate**

### Primary Driver 1: Activation

Measures how effectively users move through the onboarding funnel.

**Sub-drivers:**

- Landing Page Visit Rate
- Trial Start Rate
- Onboarding Completion Rate

### Primary Driver 2: Engagement

Measures how actively users interact with the product.

**Sub-drivers:**

- Engagement Score
- Product Usage Frequency
- Feature Adoption

### Primary Driver 3: Monetization

Measures revenue contribution from converted users.

**Sub-drivers:**

- Revenue per User
- Premium Plan Adoption
- Upgrade Rate

### Guardrail Metrics

The following metrics were monitored to ensure business quality was maintained:

- Refund Rate
- Support Ticket Rate
- Days to Convert
- Engagement Score

---

# Experiment Result Summary

| Metric | Control | Treatment |
|----------|----------|----------|
| User Count | 693 | 715 |
| Landing Page Visit Rate | 63.6% | 72.6% |
| Trial Start Rate | 25.1% | 29.1% |
| Onboarding Completion Rate | Higher in Treatment | Higher in Treatment |
| Paid Conversion Rate | 3.17% | 6.99% |
| Average Engagement Score | 57.03 | 62.93 |
| Average Days to Convert | 8.86 | 6.40 |
| Refund Rate | 0.00% | 0.42% |
| Support Ticket Rate | 0.22 | 0.37 |

### Key Findings

- Paid Conversion Rate increased from 3.17% to 6.99%.
- Absolute lift: 3.82 percentage points.
- Relative lift: 120.5%.
- Engagement Score increased significantly.
- Users converted faster in the Treatment group.
- Small increases were observed in refunds and support tickets.

---

# Hypothesis Test Interpretation

## Test Used

Two-Proportion Z-Test

### Hypotheses

**Null Hypothesis (H₀):**

The Treatment onboarding experience does not improve Paid Conversion Rate.

**Alternative Hypothesis (H₁):**

The Treatment onboarding experience improves Paid Conversion Rate.

### Test Results

| Metric | Value |
|----------|----------|
| Control Conversion Rate | 3.17% |
| Treatment Conversion Rate | 6.99% |
| Z-Statistic | 3.252 |
| P-Value | 0.00057 |
| Alpha | 0.05 |

### Decision

Since:

**0.00057 < 0.05**

Reject the Null Hypothesis.

### Interpretation

The improvement in Paid Conversion Rate is statistically significant and unlikely to be due to random chance.

This provides strong evidence that the Treatment onboarding experience outperforms the existing onboarding process.

---

# Guardrail Analysis

## Refund Rate

| Group | Refund Rate |
|---------|---------|
| Control | 0.00% |
| Treatment | 0.42% |

### Assessment

A small increase in refunds was observed in the Treatment group.

### Risk Level

Low to Moderate

---

## Support Ticket Rate

| Group | Support Ticket Rate |
|---------|---------|
| Control | 0.22 |
| Treatment | 0.37 |

### Assessment

Support requests increased in the Treatment group.

### Risk Level

Moderate

Additional investigation is recommended to identify friction points within the onboarding experience.

---

## Days to Convert

| Group | Average Days |
|---------|---------|
| Control | 8.86 |
| Treatment | 6.40 |

### Assessment

Users converted faster under the Treatment experience.

### Risk Level

Low

### Business Impact

Positive

---

## Engagement Score

| Group | Average Score |
|---------|---------|
| Control | 57.03 |
| Treatment | 62.93 |

### Assessment

User engagement improved substantially.

### Risk Level

Low

### Business Impact

Positive

---

# Segment-Level Insights

## Region Analysis

The Treatment experience demonstrated positive conversion performance across all major geographic regions.

No region experienced a material decline in conversion performance.

## Device Type Analysis

Both desktop and mobile users benefited from the Treatment onboarding experience.

No device segment showed evidence of performance deterioration.

## Traffic Source Analysis

The Treatment experience generated higher engagement and conversion across major acquisition channels.

Performance improvements were consistent across traffic sources, indicating broad applicability of the onboarding campaign.

---

# Final Recommendation

## Recommendation: Launch (Phased Rollout)

The Treatment onboarding experience should be rolled out to users through a phased deployment strategy.

### Justification

1. Paid Conversion Rate increased from 3.17% to 6.99%.
2. Statistical testing confirmed significance (p-value = 0.00057).
3. Engagement Score improved significantly.
4. Users converted more quickly.
5. Improvements were observed across key segments.
6. Guardrail risks remain manageable.

---

# Risks and Limitations

## Risks

- Increased support ticket volume may increase operational costs.
- Refund requests may indicate some users are converting before fully understanding the product.
- Long-term retention effects have not yet been measured.

## Limitations

- Experiment duration may not capture long-term customer behavior.
- Revenue quality beyond the first 30 days was not evaluated.
- Additional testing may be required to validate performance over time.

---

# Next Steps

1. Deploy the Treatment experience to a larger percentage of users.
2. Monitor conversion rate weekly.
3. Monitor support ticket volume and refund rate closely.
4. Conduct qualitative analysis on support ticket themes.
5. Measure retention and revenue performance after 60 and 90 days.
6. Continue segment-level monitoring to identify any emerging issues.
7. Reassess the onboarding experience after sufficient post-launch data has been collected.

---

# Final Business Decision

**Recommended Action: Launch (Phased Rollout)**

The Treatment onboarding experience delivers statistically significant improvements in the North Star Metric while maintaining acceptable guardrail performance. Although some operational risks exist, the expected business benefits outweigh the identified concerns.